S. Wongnarkpet et al., An on-farm study of the epidemiology of Actinobacillus pleuropneumoniae infection in pigs as part of a vaccine efficacy trial, PREV VET M, 39(1), 1999, pp. 1-11
Thirty cohort pigs were followed from birth to slaughter to study epidemiol
ogical patterns of porcine pleuropneumonia caused by Actinobacillus pleurop
neumoniae. The study was conducted within a larger 380-animal study of vacc
ination against Mycoplasma hyopneumoniae and A. pleuropneumoniae in a 340-s
ow farrow-to-finish piggery with 4-month weaning, operating a continuous sy
stem of intensive production in the North Island of New Zealand. The cohort
pigs were randomly allocated into two equal groups: vaccinated and control
. Pigs in the first group were vaccinated at 2 and 4 weeks of age with both
M. hyopneumoniae vaccine and A. pleuropneumoniae vaccine at separate vacci
nation sites. A series of nasal swabs was taken at 4, 8, 10, 11, 12, 14, 16
and 18 weeks of age. Each swab was streaked onto the surface of a selectiv
e medium on the farm and the plates were immediately transported to a labor
atory and incubated at 37 degrees C for 5 days. After the trial, pigs were
slaughtered at an average of 132 days of age, lungs were examined and sampl
es taken for bacteriological culture and isolation. Thirty-five out of 256
samples produced haemolytic colonies which were Gram-negative, V-factor-dep
endent and positive to the CAMP test. A. pleuropneumoniae was first isolate
d at 4 weeks of age from one vaccinated pig. This finding suggests that pig
lets became infected in the farrowing pen and the source of infection might
be a carrier sow. The interval-specific cumulative incidence of A. pleurop
neumoniae infection reached a maximum of 54% and 40% at ii weeks of age in
the vaccinated and control groups, respectively. Infection status of the li
tter is considered to be a factor influencing morbidity in infected herds d
uring weaner and grower periods. Our results suggest that simultaneous vacc
ination with M. hyopneumoniae and A. pleuropneumoniae vaccines at 2 and 4 w
eeks of age might lessen the prevalence but cannot absolutely prevent A. pl
europneumoniae infection during the weaner or grower-finisher periods. (C)
1999 Elsevier Science B.V. All rights reserved.